Allergic Conjunctivitis (AC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Allergic Conjunctivitis (AC) Marketed and Pipeline Drugs Report Overview
Allergic conjunctivitis (AC) is an inflammatory response of the conjunctiva to an allergen or irritant such as pollen, dust, and mold. It is part of a larger systemic atopic reaction and is usually seasonal, with associated upper respiratory tract symptoms and complaints of redness and swelling of the conjunctiva, with severe itching and increased lacrimation. It has been estimated that that the highest diagnosed prevalence of AC will be in China, India, and the US by 2028.
The AC marketed and pipeline drugs market research report includes an assessment of the disease epidemiology, leading marketed products with sales forecast, and late-to-mid-stage pipeline products with Phase Transition Success Rate (PTSR) and Likelihood of Approval (LoA) for allergic conjunctivitis (AC). The report also analyzes the clinical and commercial landscapes of AC, as well as an assessment of deals, future market catalysts, key market players, and the future competitive environment.
Allergic Conjunctivitis Marketed Drugs Segmentation by Mechanism of Action
The key mechanisms of action for AC marketed drugs are receptor agonist, receptor antagonist, enzyme inhibitor, cells and cell organelle inhibitor, ion channel blocker, biological factor inhibitor, cells and cell organelle disrupter, ligand inhibitor, and enzyme activator. The mechanism of action for most marketed drugs for AC is receptor agonist.
Allergic Conjunctivitis Marketed Drugs Analysis by MoA, 2023 (%)
For more MoA insights into AC marketed drugs, download a free report sample
AC Marketed Drugs Segmentation by Routes of Administration
The key routes of administration for AC marketed drugs are oral, topical, injection, inhalation, and suppository. Most marketed drugs for AC are oral therapies, followed by topicals.
Allergic Conjunctivitis Marketed Drugs Analysis by RoA, 2023 (%)
For more RoA insights into the AC marketed drugs, download a free report sample
Allergic Conjunctivitis Pipeline Drugs Segmentation by Mechanisms of Action
The key mechanisms of action for AC pipeline drugs are receptor antagonist, enzyme inhibitor, biological factor inhibitor, ion channel blocker, cytotoxic to cell, ion channel activator, ligand inhibitor, protein and peptide inhibitor, and receptor agonist. Most of the AC pipeline drugs are receptor antagonists.
Allergic Conjunctivitis Pipeline Drugs Analysis by MoA, 2023 (%)
For more MoA insights into the AC pipeline drugs market, download a free report sample
AC Pipeline Drugs Segmentation by Routes of Administration
The key routes of administration for AC pipeline drugs are topical, oral, injection, inhalation, and suppository. The pipeline drugs for AC are mostly topical therapies, followed by oral.
Allergic Conjunctivitis Pipeline Drugs Analysis by RoA, 2023 (%)
For more RoA insights into the AC pipeline drugs market, download a free report sample
Allergic Conjunctivitis Pipeline Drugs Segmentation by Molecule Type
Most of the pipeline drugs for AC are small molecules. Biologic and oligonucleotide are the other significant molecule type in the pipeline drugs for AC.
Allergic Conjunctivitis Pipeline Drugs Analysis by Molecule Types, 2023 (%)
For more molecule type insights into the AC pipeline drugs market, download a free report sample
Top Sponsors in the AC Marketed and Pipeline Drugs Market
Some of the top sponsors in the AC marketed and pipeline drugs market are Aldeyra Therapeutics Inc, Santen Pharmaceutical Co Ltd, NicOx SA, Ajanta Pharma Ltd, Alcon Inc, Atoll, Ora Inc, Micro Labs Inc, Faes Pharma SA, and Carisma Therapeutics Inc. Among the key players, Santen Pharmaceutical has been sponsoring the highest number of Phase III trials.
Allergic Conjunctivitis Marketed Drugs Report Overview
| Key Mechanisms of Action | Receptor Agonist, Receptor Antagonist, Enzyme Inhibitor, Cells and Cell Organelle Inhibitor, Ion Channel Blocker, Biological Factor Inhibitor, Cells and Cell Organelle Disrupter, Ligand Inhibitor, and Enzyme Activator |
| Key Routes of Administration | Oral, Topical, Injection, Inhalation, and Suppository |
Allergic Conjunctivitis Pipeline Drugs Market Report Overview
| Key Mechanisms of Action | Receptor Antagonist, Receptor Agonist, Enzyme Inhibitor, Cytotoxic to Cell, and Transporter Activator |
| Key Routes of Administration | Topical, Oral, Injection, Inhalation and Suppository |
| Key Molecule Types | Small Molecule, Biologic, and Oligonucleotide |
| Top Sponsors (Marketed and Pipeline Drugs) | Aldeyra Therapeutics Inc, Santen Pharmaceutical Co Ltd, NicOx SA, Ajanta Pharma Ltd, Alcon Inc, Atoll, Ora Inc, Micro Labs Inc, Faes Pharma SA, and Carisma Therapeutics Inc |
Segments Covered in the Report
AC Marketed Drugs Mechanisms of Action Outlook (Number of Drugs, 2023)
- Receptor Agonist
- Receptor Antagonist
- Enzyme Inhibitor
- Cells and Cell Organelle Inhibitor
- Ion Channel Blocker
- Biological Factor Inhibitor
- Cells and Cell Organelle Disrupter
- Ligand Inhibitor
- Enzyme Activator
AC Marketed Drugs Routes of Administration Outlook (Number of Drugs, 2023)
- Oral
- Topical
- Injection
- Inhalation
- Suppository
AC Pipeline Drugs Mechanisms of Action Outlook (Number of Drugs, 2023)
- Receptor Antagonist
- Receptor Agonist
- Enzyme Inhibitor
- Cytotoxic to Cell
- Transporter Activator
AC Pipeline Drugs Routes of Administration Outlook (Number of Drugs, 2023)
- Topical
- Oral
- Injection
- Inhalation
- Suppository
AC Pipeline Drugs Molecule Types Outlook (Number of Drugs, 2023)
- Small Molecule
- Biologic
- Oligonucleotide
Scope
GlobalData’s Allergic Conjunctivitis (AC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.
Components of the report include:
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Breakdown by Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Pricing and Reimbursement Assessment
- Annual Therapy Cost
- Time to Pricing and Time to Reimbursement
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
- Product Profiles with Sales Forecast
- Late-to-mid-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the AC market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global AC market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
Frequently asked questions
-
What are the key mechanisms of action for AC marketed drugs?
The key mechanisms of action for AC marketed drugs are receptor agonist, receptor antagonist, enzyme inhibitor, cells and cell organelle inhibitor, ion channel blocker, biological factor inhibitor, cells and cell organelle disrupter, ligand inhibitor, and enzyme activator.
-
What are the key routes of administration for AC marketed drugs?
The key routes of administration for AC marketed drugs are oral, topical, injection, inhalation, and suppository.
-
What are the key mechanisms of action for AC pipeline drugs?
The key mechanisms of action for AC pipeline drugs are receptor antagonist, enzyme inhibitor, biological factor inhibitor, ion channel blocker, cytotoxic to cell, ion channel activator, ligand inhibitor, protein and peptide inhibitor, and receptor agonist.
-
What are the key routes of administration for AC pipeline drugs?
The key routes of administration for AC pipeline drugs are topical, oral, injection, inhalation and suppository.
-
What are the key molecule types for AC pipeline drugs?
The key molecule types in the AC pipeline drugs market are small molecule, biologic, and oligonucleotide.
-
Who are the top sponsors for AC marketed and pipeline drugs market?
Some of the top sponsors in the AC marketed and pipeline drugs market are Aldeyra Therapeutics Inc, Santen Pharmaceutical Co Ltd, NicOx SA, Ajanta Pharma Ltd, Alcon Inc, Atoll, Ora Inc, Micro Labs Inc, Faes Pharma SA, and Carisma Therapeutics Inc.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Sample Report
Allergic Conjunctivitis (AC) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
Related reports
View more Allergic Conjunctivitis reports